Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from PharmaCielo ( (TSE:PCLO) ) is now available.
PharmaCielo Ltd. has scheduled its annual general meeting of shareholders for April 2, 2026, with a record date of February 23, 2026 for investors entitled to receive notice and vote. Meeting materials will be made available to shareholders in line with applicable securities regulations.
The company also plans to issue 12,153,937 common shares at an effective price of $0.08 per share to satisfy $972,317.12 in accrued semi-annual interest owed on its 11% secured debentures, subject to TSX Venture Exchange approval. The move converts cash interest obligations into equity, easing near-term cash outflows while modestly diluting existing shareholders, and the new shares will remain subject to any remaining statutory hold periods under Canadian securities laws.
The most recent analyst rating on (TSE:PCLO) stock is a Hold with a C$0.08 price target. To see the full list of analyst forecasts on PharmaCielo stock, see the TSE:PCLO Stock Forecast page.
Spark’s Take on TSE:PCLO Stock
According to Spark, TipRanks’ AI Analyst, TSE:PCLO is a Neutral.
The score is primarily held down by weak financial performance (declining revenue, deeply negative margins, ongoing cash burn, and negative equity). Technicals are supportive due to the price trading above major moving averages and a positive MACD, but the extremely overbought RSI increases near-term risk. Valuation is difficult to assess with negative earnings and no stated dividend yield.
To see Spark’s full report on TSE:PCLO stock, click here.
More about PharmaCielo
PharmaCielo Ltd. is a Canada-headquartered global company focused on the ethical and sustainable cultivation, processing and supply of all-natural, pharmaceutical-grade medical dried cannabis flower and cannabis extracts. Through its wholly owned Colombian subsidiary, based at a cultivation and processing center in Rionegro, it targets the natural pharmaceuticals and consumer products markets.
Average Trading Volume: 140,205
Technical Sentiment Signal: Hold
Current Market Cap: C$10.76M
Learn more about PCLO stock on TipRanks’ Stock Analysis page.